See leaflet
Dapibus®
dasatinib
Indications
- Adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase
- Adults with chronic, accelerated, or myeloid or lymphoid blast phase Ph+ CML with resistance or intolerance to prior therapy including imatinib.
- Adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance or intolerance to prior therapy.
Presentations
- 50 mg x 60 tablets
- 100 mg x 30 tablets
- 50 mg x 60 tablets
- 100 mg x 30 tablets